Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure
Rima Kamel, Jérôme Leroy, Grégoire Vandecasteele, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 2, pp. 90-108
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Astragaloside IV derivative HHQ16 ameliorates infarction-induced hypertrophy and heart failure through degradation of lncRNA4012/9456
Jingjing Wan, Zhen Zhang, Chennan Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 28
Phosphodiesterase in heart and vessels: from physiology to diseases
Qin Fu, Ying Wang, Chen Yan, et al.
Physiological Reviews (2023) Vol. 104, Iss. 2, pp. 765-834
Open Access | Times Cited: 18
PDE4 inhibitors: potential protective effects in inflammation and vascular diseases
Tianfei Fan, Wenjing Wang, Yao Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Extracellular vesicles in cardiovascular diseases: From pathophysiology to diagnosis and therapy
Yuxin Du, Lin Wu, Litao Wang, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 74, pp. 40-55
Closed Access | Times Cited: 15
Cardiac Gene Therapy With Phosphodiesterase 2A Limits Remodeling and Arrhythmias in Mouse Models of Heart Failure
Rima Kamel, Aurélia Bourcier, Jean Piero Margaria, et al.
Journal of the American Heart Association (2025) Vol. 14, Iss. 3
Open Access
Role of PDE4 Family in Cardiomyocyte Physiology and Heart Failure
Ivan Sherstnev, Aleksandra Judina, Giovanni Battista Luciani, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 460-460
Open Access
Clebopride stimulates 5-HT4-serotonin receptors in the human atrium
Lina Maria Rayo Abella, Joachim Neumann, Britt Hofmann, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
MiR-133b-3p attenuates angiotensin II-induced cardiac hypertrophy through the inhibition of apoptosis by targeting <italic>CDIP1</italic>
Jiwei Gu, Zhen Li, Xinyi Li, et al.
Acta Biochimica et Biophysica Sinica (2025)
Open Access
Phosphodiesterases 4B and 4D Differentially Regulate cAMP Signaling in Calcium Handling Microdomains of Mouse Hearts
Axel E. Kraft, Nadja I. Bork, Hariharan Subramanian, et al.
Cells (2024) Vol. 13, Iss. 6, pp. 476-476
Open Access | Times Cited: 3
Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression
Z. X. Jiang, Qianlong Kang, Hong Qian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Rethinking of phosphodiesterase 5 inhibition: the old, the new and the perspective in human health
Maria Paola Paronetto, Clara Crescioli
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Mutations in Phosphodiesterase 3A ( PDE3A ) Cause Hypertension Without Cardiac Damage
Maria Ercu, Stephan Walter, Enno Klußmann
Hypertension (2023) Vol. 80, Iss. 6, pp. 1171-1179
Closed Access | Times Cited: 7
Abnormal phosphorylation / dephosphorylation and Ca2+ dysfunction in heart failure
Yanbing Liu, Qian Wang, Yuling Song, et al.
Heart Failure Reviews (2024) Vol. 29, Iss. 4, pp. 751-768
Closed Access | Times Cited: 2
Liraglutide ameliorates TAC-induced cardiac hypertrophy and heart failure by upregulating expression level of ANP expression
Ruisha Li, Keyin Zhang, Zhenjun Xu, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e32229-e32229
Open Access | Times Cited: 2
Histone methyltransferase MLL4 protects against pressure overload-induced heart failure via a THBS4-mediated protection in ER stress
Xiangmin Meng, Qiuyu Pang, Zhenfang Zhou, et al.
Pharmacological Research (2024) Vol. 205, pp. 107263-107263
Open Access | Times Cited: 2
The therapeutic potential of phosphodiesterase 9 (PDE9) inhibitors: a patent review (2018-present)
Chen Zhang, Zhao-Hang Xue, Weihao Luo, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 9, pp. 759-772
Closed Access | Times Cited: 2
Pharmacological strategies for mitigating anti-TNF biologic immunogenicity in rheumatoid arthritis patients
Christian A. Fernandez
Current Opinion in Pharmacology (2022) Vol. 68, pp. 102320-102320
Open Access | Times Cited: 12
PDE4 Phosphodiesterases in Cardiovascular Diseases: Key Pathophysiological Players and Potential Therapeutic Targets
Lídia Puertas-Umbert, Judith Alonso, Leif Hove‐Madsen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 17017-17017
Open Access | Times Cited: 6
Clinical pharmacology of cardiac cyclic AMP in human heart failure: too much or too little?
Anastasios Lymperopoulos
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 7, pp. 623-630
Open Access | Times Cited: 5
Identification of TGF-β-related genes in cardiac hypertrophy and heart failure based on single cell RNA sequencing
Kai Huang, Hao Wu, Xiangyang Xu, et al.
Aging (2023) Vol. 15, Iss. 14, pp. 7187-7218
Open Access | Times Cited: 5
Artificial intelligence utility for drug development: ChatGPT and beyond
David Gurwitz, Noam Shomron
Drug Development Research (2023)
Open Access | Times Cited: 4
Effects of hallucinogenic drugs on the human heart
Joachim Neumann, Stefan Dhein, Uwe Kirchhefer, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
The water extract of Amydrium sinense (Engl.) H. Li ameliorates Isoproterenol-induced cardiac hypertrophy through inhibiting the NF-κB signaling pathway
Bingmin Wu, Ruiyan Zheng, Minhua Ouyang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116241-116241
Open Access | Times Cited: 1
Carvedilol Activates a Myofilament Signaling Circuitry to Restore Cardiac Contractility in Heart Failure
Ying Wang, Meimi Zhao, Xianhui Liu, et al.
JACC Basic to Translational Science (2024) Vol. 9, Iss. 8, pp. 982-1001
Open Access | Times Cited: 1
Unlocking the secrets of Cardiac development and function: the critical role of FHL2
Tingting Jiang, Qun Zeng, Jing Wang
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top